![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Yichang Sanxia Proudin Biopharmaceutical Co., Ltd. Yichang Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Leucine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-459 - Rev 00
This Chemical Type CEP, issued on June 25, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 771 associated with this CEP further emphasizes